Diagnostic Evidence Co-operative Newcastle

The Diagnostic Evidence Co-operative Newcastle is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.

The NIHR DEC Newcastle facilitates the generation of high quality evidence on clinical validity, utility and cost-effectiveness of in vitro diagnostic medical devices (IVDs) for use in the NHS.
For more information see About us

News & Developments


SBRI Healthcare competition announcement

A search for innovations with the ability to transform cancer screening, and facilitate earlier and faster diagnosis launches on 25 July 2017. See AHSN website for details of briefing sessions

Calling all industry experts: Help the NIHR improve the industry section of its website
The short questionnaire should take no longer than 10 minutes to complete and will help the NIHR ensure the content is meeting the needs of its customers. Don’t miss out take part in the review by 31 July 2017

New publication

Clinical performance and economic evaluations of the Alere™ i Influenza A&B
This first prospective study of the Alere™ i NPT using throat swabs demonstrates high specificity, high PPV during seasonal epidemics, and rapid result availability which could lead to substantial cost savings. Journal of Hospital Infection.

Diagnostic Evidence Workshop 2017
Thursday, 28 September 2017 to Friday, 29 September 2017, 9am - 4pm
NIHR Diagnostic Evidence Co-operative (DEC) Oxford two day course on diagnostic test development, evaluation and regulation. This course is aimed at all professionals working on diagnostic tests including those working in industry, academia, funding and regulation. To register go to the DEC Oxford website

Industrial Strategy Challenge Fund (ISCF)
Following the announcement in the Spring Budget,  Innovate UK will be inviting industry-led proposals within the first round of the new Industrial Strategy Challenge Fund.
The “Challenge Areas” are likely to include:
Antimicrobial resistance
        Utilising new technologies and treatments to reduce AMR by 50%             by 2025/30
Innovation in health & disease detection using diagnostic,                     preventative & sensor technologies
        Developing diagnostics and sensors that enable anticipation and             prevention of disease in the healthy, elderly and chronically ill. To             precisely diagnose and treat disease in the ill, to improve                             compliance with medication, and to enable independent living.

The NIHR DEC Newcastle and it partners would be very pleased to discuss working with firms or consortia planning to lead ISCF bids. 

Are you set for the Medical Devices Regulations?

Read here for more information and see the following BSI report

£££ See here for recent funding opportunities £££ 

The DEC is funded by the NIHR